BioAdaptives' MyndMed Receives WADA-Compliant Certification, Opening UFC Integration

August 20th, 2025 5:06 PM
By: Newsworthy Staff

BioAdaptives' nootropic supplement MyndMed achieved WADA-compliant certification from TruShield Laboratory Services, enabling its potential inclusion in UFC's approved supplement program for athletes seeking cognitive enhancement without doping risks.

BioAdaptives' MyndMed Receives WADA-Compliant Certification, Opening UFC Integration

BioAdaptives, Inc. (OTCMKTS: BDPT) announced that its nootropic formula MyndMed received certification as clean from TruShield Laboratory Services following comprehensive testing for World Anti-Doping Agency compliance. The certification confirms that MyndMed contains no banned substances and meets rigorous safety standards required for competitive athletes, particularly those in professional sports organizations that adhere to WADA guidelines.

The significance of this certification extends beyond mere regulatory compliance, as it positions MyndMed for potential integration into the Ultimate Fighting Championship's approved supplement pool. This development matters because it addresses a critical need in professional sports: providing athletes with cognitive performance support while eliminating the risk of anti-doping violations. For UFC fighters and other professional athletes, access to certified cognitive enhancers like MyndMed could offer legitimate advantages in focus, reaction time, and mental clarity without compromising their competitive eligibility or career longevity.

TruShield's endorsement carries substantial weight in the sports community, as the laboratory's protocols are trusted by major professional sports organizations including the UFC. This certification matters because it establishes a new standard for cognitive enhancement supplements in regulated sports environments, potentially influencing how other supplement manufacturers approach product development and testing. The implications extend to athlete safety, competitive fairness, and the broader sports nutrition industry's alignment with anti-doping standards.

The certification enables BioAdaptives to market MyndMed specifically to athletes who must maintain WADA compliance, creating a distinct competitive advantage in the sports nutrition market. This development is important because it bridges the gap between cognitive enhancement and regulatory compliance, offering a solution that could reduce accidental doping incidents among athletes using supplements. For more information about BioAdaptives' products, visit https://www.bioadaptives.com.

This achievement represents a significant milestone in the convergence of sports nutrition and anti-doping compliance, potentially setting a precedent for how cognitive enhancement supplements are developed, tested, and integrated into professional sports programs worldwide. The certification matters not only for current athletes but also for the future of sports supplement regulation and athlete safety protocols across multiple sporting disciplines.

Source Statement

This news article relied primarily on a press release disributed by InvestorBrandNetwork (IBN). You can read the source press release here,

blockchain registration record for the source press release.
;